High-Value Federal Grants ($5M+) — August 07, 2026

Merck won a $236.3M cost-plus-fixed-fee contract (2017-2027) and a $155.8M firm-fixed-price ERVEBO contract (2024-2034), totaling $392M in obligations from HHS/BARDA, signaling deep government reliance on Merck for biodefense and pandemic preparedness.

AT&T Enterprises secured a $182.1M task order under full-and-open competition for domestic telecom services, with a total potential value of $1.17B including options, indicating strong competitive positioning and long-term recurring revenue visibility.

SENTURE secured a $105.6M firm-fixed-price delivery order from FMCSA for IT support, with the full obligation already outlayed, reducing payment risk and providing predictable revenue through August 2025.

The $388.5M cost-plus-fixed-fee contract from NASA Goddard ended in 2022, with $220.9M outlayed; while the 8(a) set-aside provided a competitive moat, the contract's completion means no forward revenue from this award.

Merck Sharp & Dohme accounts for 31% of total digest value ($392M of $1.26B) across two BARDA contracts, creating single-entity dependency risk for investors tracking HHS biodefense spending.

Suffolk Construction's $88.2M firm-fixed-price VA hospital boiler replacement (2026-2029) carries cost-overrun risk on a fixed-price infrastructure project, with no set-aside protection.

The Merck ERVEBO contract ($155.8M) was not competed, raising questions about pricing transparency and potential protest risk if competitors challenge the sole-source justification.

Serco Limited's subsidiary Whitney Bradley & Brown's $108M GSA delivery order for defense aircraft R&D (2017-2024) suggests ongoing demand for defense systems engineering support; watch for follow-on contracts as the January 2024 end date has passed.

AT&T's $182M State Department telecom task order with $1.17B option ceiling signals potential for telecom infrastructure modernization across civilian agencies; similar opportunities may exist at DHS, DOJ, and Treasury.

Arctic Slope Technical Services' completed $388.5M NASA contract demonstrates the revenue potential of 8(a) set-asides for Alaskan Native Corporations; investors should monitor for new 8(a) opportunities at NASA and other agencies.

Merck's two awards totaling $392M from BARDA (2017-2034) underscore sustained government investment in biodefense and pandemic preparedness, with both cost-plus and firm-fixed-price structures providing revenue visibility.

AT&T's $182M State Department telecom award and SENTURE's $105.6M DOT IT support contract demonstrate ongoing civilian agency investment in telecommunications and data management infrastructure.

{"entity" => "Merck & Co., Inc.", "reason" => "Dual BARDA awards ($392M) represent 31% of digest value; option exercise and follow-on contracts will signal continued government confidence.", "trigger" => "Option exercise on ERVEBO contract ($17.8M); BARDA FY2027 budget appropriations; public disclosure of contract scope"}

{"entity" => "AT&T Enterprises, LLC", "reason" => "State Department telecom contract has $1.17B option ceiling; option exercises will determine actual revenue realization.", "trigger" => "Option exercise announcements; State Department telecom budget releases; re-compete for similar services"}

{"entity" => "SENTURE LLC", "reason" => "DOT contract fully funded ($105.6M outlayed); approaching August 2025 end date creates re-compete catalyst.", "trigger" => "FMCSA re-compete solicitation for CIRIS services; SENTURE's quarterly revenue disclosures"}

{"entity" => "Serco Limited", "reason" => "Whitney Bradley & Brown contract ended January 2024; follow-on awards will indicate pipeline health.", "trigger" => "New GSA or DOD awards for defense aircraft R&D; Serco earnings calls mentioning Warner Robins work"}